ESC Boston and BIOMED Boston is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BIOMEDevice Boston 2019 Schedule Viewer

 

Welcome to the Biomed Boston & ESC Boston 2019 Presentation Store. Here you can view and download conference and/or show floor theater presentations before, during, and after the event. If you’re looking for a presentation from a specific session that you’re unable to find here, note that it’s likely because the presenter has not provided permission for external use or has not yet shared their presentation with us. Please check back after the event for a more complete catalogue of available presentations.

Robotics Between Fantasy & Reality

Fady Saad (Co-Founder & Director of Partnerships, MassRobotics)

Location: Engineering Theater

Date: Wednesday, May 15

Time: 10:15am - 11:00am

Track: Engineering Theater

Vault Recording: TBD

Studies have been predicting that the worldwide spending on robotics will reach $67 billion by 2025, and that robotics will have a global potential impact economic impact of more than $1 trillion. In addition global sales of commercial drones is predicted to reach $1 billion by 2020, and manufacturing and logistics robots sales to reach $31 billion by the same year. No doubt that there are massive opportunities for the robotics industry and people who are leading it, but the challenge is that talking about robotics in general terms is sometimes misleading, and it’s always important to highlight which vertical we are discussing and what are the relevant opportunities in this particular sector. During this talk we would be discussing some of the evolving trends in the robotics market based on the presenter experience in co-founding the US leading robotics startups innovation hub, MassRobotics, and interacting with many startups, corporates, investors, and academic institutions.



1